These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2676535)

  • 41. [New amiodarone protocol in the treatment of refractory arrhythmias].
    Salamé E; Checrallah E; Abou Jaoudé S; Halaby J
    J Med Liban; 1992; 40(4):187-9. PubMed ID: 1339904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beta-blockade by sotalol in early myocardial infarction decreases ventricular arrhythmias without increasing left ventricular volume.
    Lloyd EA; Charles RG; Gordon GD; Adams CM; Mabin TA; Commerford PJ; Opie LH
    S Afr Med J; 1988 Jul; 74(1):5-10. PubMed ID: 3291150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses.
    Anderson JL; Askins JC; Gilbert EM; Miller RH; Keefe DL; Somberg JC; Freedman RA; Haft LR; Mason JW; Lessem JN
    J Am Coll Cardiol; 1986 Oct; 8(4):752-62. PubMed ID: 2428852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and adverse effects of sotalol in adults with congenital heart disease.
    Moore BM; Cordina RL; McGuire MA; Celermajer DS
    Int J Cardiol; 2019 Jan; 274():74-79. PubMed ID: 29954667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of amiodarone on ventricular arrhythmias during and after acute myocardial infarction.
    Hockings BE; George T; Mahrous F; Taylor RR; Hajar HA
    Am J Cardiol; 1987 Nov; 60(13):967-70. PubMed ID: 3673913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short- and long-term antiarrhythmic and hemodynamic effects of d,l-sotalol in patients with symptomatic ventricular arrhythmias.
    Hohnloser SH; Zabel M; Krause T; Just H
    Am Heart J; 1992 May; 123(5):1220-4. PubMed ID: 1575137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia.
    Man KC; Williamson BD; Niebauer M; Daoud E; Bakr O; Strickberger SA; Hummel JD; Kou W; Morady F
    Am J Cardiol; 1994 Dec; 74(11):1119-23. PubMed ID: 7977070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sotalol in patients with life-threatening ventricular tachyarrhythmias.
    Trappe HJ; Klein H; Lichtlen P
    Cardiovasc Drugs Ther; 1990 Oct; 4(5):1425-32. PubMed ID: 2278875
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of d-sotalol, a pure class III antiarrhythmic compound, in patients with symptomatic complex ventricular ectopy. Results of a multicenter, randomized, double-blind, placebo-controlled dose-finding study. The d-Sotalol PVC Study Group.
    Hohnloser SH; Meinertz T; Stubbs P; Crijns HJ; Blanc JJ; Rizzon P; Cheuvart B
    Circulation; 1995 Sep; 92(6):1517-25. PubMed ID: 7664435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
    Fogoros RN; Anderson KP; Winkle RA; Swerdlow CD; Mason JW
    Circulation; 1983 Jul; 68(1):88-94. PubMed ID: 6851057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Replacement of amiodarone by sotalol for repetitive ventricular premature beats.
    Burckhardt D; White RA; Hoffmann A
    Am Heart J; 1984 Jan; 107(1):167-8. PubMed ID: 6691226
    [No Abstract]   [Full Text] [Related]  

  • 52. Use of intravenous amiodarone for emergency treatment of life-threatening ventricular arrhythmias.
    Helmy I; Herre JM; Gee G; Sharkey H; Malone P; Sauve MJ; Griffin JC; Scheinman MM
    J Am Coll Cardiol; 1988 Oct; 12(4):1015-22. PubMed ID: 3417974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure.
    Cleland JG; Dargie HJ; Findlay IN; Wilson JT
    Br Heart J; 1987 May; 57(5):436-45. PubMed ID: 3297121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term sotalol therapy in patients with ventricular arrhythmias.
    Mary-Rabine L; Soumagne D; Stiels B
    Acta Cardiol; 1986; 41(2):89-97. PubMed ID: 2424202
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Evaluation of the use of amiodarone in outpatients].
    Castro I; Poma N; Rodrigues R
    Arq Bras Cardiol; 1989 Oct; 53(4):207-9. PubMed ID: 2629677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sotalol versus class I and II antiarrhythmic agents.
    Hanyok JJ; MacNeil DJ
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():603-11. PubMed ID: 2275890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study.
    Hohnloser SH; Meinertz T; Dammbacher T; Steiert K; Jähnchen E; Zehender M; Fraedrich G; Just H
    Am Heart J; 1991 Jan; 121(1 Pt 1):89-95. PubMed ID: 1985383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sotalol for refractory sustained ventricular tachycardia and nonfatal cardiac arrest.
    Singh SN; Cohen A; Chen YW; Wish M; Thoben-O'Grady L; Peralba J; Gottdiener J; Fletcher RD
    Am J Cardiol; 1988 Sep; 62(7):399-402. PubMed ID: 2458026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relation between ventricular function and antiarrhythmic responses to sotalol.
    Singh SN; Chen YW; Cohen A; Obeid M; Tracy C; Woosley RL; Fletcher RD
    Am J Cardiol; 1989 Oct; 64(14):943-5. PubMed ID: 2801566
    [No Abstract]   [Full Text] [Related]  

  • 60. Historical development of the concept of controlling cardiac arrhythmias by lengthening repolarization: particular reference to sotalol.
    Singh BN
    Am J Cardiol; 1990 Jan; 65(2):3A-11A; discussion 35A-36A. PubMed ID: 2403733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.